Dickinson Andrew D bought GILD
March 10, 2025 · Form 4 insider transaction
Dickinson Andrew D bought 4,916 shares of Gilead Sciences, Inc. at $63.91 per share, a transaction worth $314.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,916
Price
$63.91
Total value
$314.2K
InsiderDickinson Andrew D
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 10, 2025
Filing dateMarch 12, 2025
Shares owned after173,977
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.